Indivior Pharmaceuticals (INDV) Change in Receivables (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Change in Receivables of $20.0 million for Q1 2026, up 281.82% year-over-year from $5.2 million in Q1 2025, and up 433.33% quarter-over-quarter from -$6.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Change in Receivables (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Change in Receivables history runs 3 years deep, the most recent figure standing at $20.0 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 281.82% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $28.0 million (up 566.67% YoY), while the FY2025 annual figure was -$3.0 million, down 400.0% from the prior year.
- Change in Receivables for Q1 2026 stood at $20.0 million, up from -$6.0 million in the prior quarter.
- The five-year high for Change in Receivables was $20.0 million in Q1 2026, with the low at -$11.0 million in Q1 2025.
- The 3-year median for Change in Receivables is -$4.0 million (2024), against an average of $2.0 million.
- Peak annual rise in Change in Receivables reached 300.0% in 2025, while the deepest fall reached 250.0% in 2025.
- Indivior Pharmaceuticals' Change in Receivables stood at $4.0 million in 2024, then tumbled by 250.0% to -$6.0 million in 2025, then soared by 433.33% to $20.0 million in 2026.
- Business Quant data shows INDV's Change in Receivables at $20.0 million in Q1 2026, -$6.0 million in Q4 2025, and $18.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.39 Bn | 4.16 Bn | 294.00 Mn | -3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.00 Mn |
| Jun 30, 2026 | -3.00 Mn |
| Mar 31, 2026 | 20.00 Mn |
| Mar 31, 2026 | 20.00 Mn |
| Dec 31, 2025 | -6.00 Mn |
| Dec 31, 2025 | -6.00 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -11.00 Mn |
| Mar 31, 2025 | -11.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | -9.00 Mn |
| Sep 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | -4.00 Mn |
| Mar 31, 2024 | -4.00 Mn |